Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3⁺ regulatory T cells in murine colon cancer

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID: 21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19:1423-37; PMID: 24202395; http://dx.doi.org/10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Engblom C, Pfirschke C, Pittet MJ. The role of myeloid cells in cancer therapies. Nat Rev Cancer 2016; 16:447-62; PMID: 27339708; http://dx.doi.org/10.1038/nrc.2016.54
   PubMed Web of Science ®Google Scholar
• Schouppe E, De Baetselier P, Van Ginderachter JA, Sarukhan A. Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. Oncoimmunology 2012; 1:1135-45; PMID: 23170260; http://dx.doi.org/10.4161/onci.21566
   PubMed Web of Science ®Google Scholar
• Ugel S, De Sanctis F, Mandruzzato S, Bronte V. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest 2015; 125:3365-76; PMID: 26325033; http://dx.doi.org/10.1172/JCI80006
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007; 26:726-40; PMID: 17582345; http://dx.doi.org/10.1016/j.immuni.2007.06.004
   PubMed Web of Science ®Google Scholar
• Youn JI, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M et al. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013; 14:211-20; PMID: 23354483; http://dx.doi.org/10.1038/ni.2526
   PubMed Web of Science ®Google Scholar
• Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 2016; 37:208-20; PMID: 26858199; http://dx.doi.org/10.1016/j.it.2016.01.004
   PubMed Web of Science ®Google Scholar
• Ortiz ML, Kumar V, Martner A, Mony S, Donthireddy L, Condamine T, Seykora J, Knight SC, Malietzis G, Lee GH et al. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. J Exp Med 2015; 212:351-67; PMID: 25667306; http://dx.doi.org/10.1084/jem.20140835
   PubMed Web of Science ®Google Scholar
• Feng PH, Lee KY, Chang YL, Chan YF, Kuo LW, Lin TY, Chung FT, Kuo CS, Yu CT, Lin SM et al. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. Am J Respir Crit Care Med 2012; 186:1025-36; PMID: 22955317; http://dx.doi.org/10.1164/rccm.201204-0636OC
   PubMed Web of Science ®Google Scholar
• Dubeykovskaya Z, Si Y, Chen X, Worthley DL, Renz BW, Urbanska AM, Hayakawa Y, Xu T, Westphalen CB, Dubeykovskiy A et al. Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer. Nat Commun 2016; 7:10517; PMID: 26841680; http://dx.doi.org/10.1038/ncomms10517
   PubMed Web of Science ®Google Scholar
• Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 2013; 24:631-44; PMID: 24229710; http://dx.doi.org/10.1016/j.ccr.2013.10.009
   PubMed Web of Science ®Google Scholar
• Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, Park H, Shykind B, Diacovo TG, Falus A et al. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med 2011; 17:87-95; PMID: 21170045; http://dx.doi.org/10.1038/nm.2278
   PubMed Web of Science ®Google Scholar
• Kwak HJ, Liu P, Bajrami B, Xu Y, Park SY, Nombela-Arrieta C, Mondal S, Sun Y, Zhu H, Chai L et al. Myeloid cell-derived reactive oxygen species externally regulate the proliferation of myeloid progenitors in emergency granulopoiesis. Immunity 2015; 42:159-71; PMID: 25579427; http://dx.doi.org/10.1016/j.immuni.2014.12.017
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID: 19197294; http://dx.doi.org/10.1038/nri2506
   PubMed Web of Science ®Google Scholar
• Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010; 78:845-53; PMID: 19917709; http://dx.doi.org/10.1128/IAI.00524-09
   PubMed Web of Science ®Google Scholar
• Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol 2012; 189:5602-11; PMID: 23152559; http://dx.doi.org/10.4049/jimmunol.1201018
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJ, Ciampricotti M, Hawinkels LJ, Jonkers J et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015; 522:345-8; PMID: 25822788; http://dx.doi.org/10.1038/nature14282
   PubMed Web of Science ®Google Scholar
• Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, Roddie C, Henry JY, Yagita H, Wolchok JD et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med 2013; 210:1695-710; PMID: 23897981; http://dx.doi.org/10.1084/jem.20130579
   PubMed Web of Science ®Google Scholar
• Joshi NS, Akama-Garren EH, Lu Y, Lee DY, Chang GP, Li A, DuPage M, Tammela T, Kerper NR, Farago AF et al. Regulatory T Cells in tumor-associated tertiary lymphoid structures suppress anti-tumor t cell responses. Immunity 2015; 43:579-90; PMID: 26341400; http://dx.doi.org/10.1016/j.immuni.2015.08.006
   PubMed Web of Science ®Google Scholar
• Serafini P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 2008; 68:5439-49; PMID: 18593947; http://dx.doi.org/10.1158/0008-5472.CAN-07-6621
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang N, Li Q, Zhang W, Ke F, Leng Q, Wang H, Chen J, Wang H. Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 2011; 6:e19495; PMID: 21559338; http://dx.doi.org/10.1371/journal.pone.0019495
   PubMed Web of Science ®Google Scholar
• Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, Maeda Y, Hamaguchi M, Ohkura N, Sato E et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med 2016; 22:679-84; PMID: 27111280; http://dx.doi.org/10.1038/nm.4086
   PubMed Web of Science ®Google Scholar
• Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480:480-9; PMID: 22193102; http://dx.doi.org/10.1038/nature10673
   PubMed Web of Science ®Google Scholar
• Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 2015; 15:409-25; PMID: 26105538; http://dx.doi.org/10.1038/nrc3958
   PubMed Web of Science ®Google Scholar
• Ahn B, Kohanbash G, Ohkuri T, Kosaka A, Chen X, Ikeura M, Wang TC, Okada H. Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas. Oncoimmunology 2015; 4:e1047581; PMID: 26451324; http://dx.doi.org/10.1080/2162402X.2015.1047581
   PubMed Web of Science ®Google Scholar
• Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID: 17667954; http://dx.doi.org/10.1038/nrm2233
   PubMed Web of Science ®Google Scholar
• Wei TT, Lin YT, Tseng RY, Shun CT, Lin YC, Wu MS, Fang JM, Chen CC. prevention of colitis and colitis-associated colorectal cancer by a novel polypharmacological histone deacetylase inhibitor. Clin Cancer Res 2016; 22:4158-69; PMID: 27528734; http://dx.doi.org/10.1158/1078-0432.CCR-15-2379
   PubMed Web of Science ®Google Scholar
• Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008; 8:467-77; PMID: 18500231; http://dx.doi.org/10.1038/nri2326
   PubMed Web of Science ®Google Scholar
• Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Kärre K, Pettersson S, Greicius G. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 2012; 33:1231-8; PMID: 22461519; http://dx.doi.org/10.1093/carcin/bgs137
   PubMed Web of Science ®Google Scholar
• Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest 2012; 122:3127-44; PMID: 22922255; http://dx.doi.org/10.1172/JCI61067
   PubMed Web of Science ®Google Scholar
• Fujimura T, Kambayashi Y, Aiba S. Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth. Oncoimmunology 2012; 1:1433-4; PMID: 23243619; http://dx.doi.org/10.4161/onci.21176
   PubMed Web of Science ®Google Scholar
• Fujimura T, Ring S, Umansky V, Mahnke K, Enk AH. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. J Invest Dermatol 2012; 132:1239-46; PMID: 22189788; http://dx.doi.org/10.1038/jid.2011.416
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9; PMID: 15322536; http://dx.doi.org/10.1038/nm1093
   PubMed Web of Science ®Google Scholar
• Yuan XL, Chen L, Li MX, Dong P, Xue J, Wang J, Zhang TT, Wang XA, Zhang FM, Ge HL et al. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 2010; 134:277-88; PMID: 19900843; http://dx.doi.org/10.1016/j.clim.2009.10.005
   PubMed Web of Science ®Google Scholar
• Kluger MA, Luig M, Wegscheid C, Goerke B, Paust HJ, Brix SR, Yan I, Mittrücker HW, Hagl B, Renner ED et al. Stat3 programs Th17-specific regulatory T cells to control GN. J Am Soc Nephrol 2014; 25:1291-302;PMID:24511136;http://dx.doi.org/10.1681/ASN.2013080904
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014; 41:14-20; PMID: 25035950; http://dx.doi.org/10.1016/j.immuni.2014.06.008
   PubMed Web of Science ®Google Scholar
• Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 2016; 7:12150; PMID: 27381735; http://dx.doi.org/10.1038/ncomms12150
   PubMed Web of Science ®Google Scholar
• Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan ZR, Roberts AI, Zhang L, Zheng B et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha. Cell Stem Cell 2012; 11:812-24; PMID: 23168163; http://dx.doi.org/10.1016/j.stem.2012.08.013
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11:762-74; PMID: 21984070; http://dx.doi.org/10.1038/nri3070
   PubMed Web of Science ®Google Scholar
• Hart KM, Usherwood EJ, Berwin BL. CX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer. Immunol Cell Biol 2014; 92:499-508; PMID: 24613975; http://dx.doi.org/10.1038/icb.2014.13
   PubMed Web of Science ®Google Scholar
• Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117:185-94; PMID: 17200718; http://dx.doi.org/10.1172/JCI28549
   PubMed Web of Science ®Google Scholar
• Lee BP, Chen W, Shi H, Der SD, Forster R, Zhang L. CXCR5/CXCL13 interaction is important for double-negative regulatory T cell homing to cardiac allografts. J Immunol 2006; 176:5276-83; PMID: 16621993; http://dx.doi.org/10.4049/jimmunol.176.9.5276
   PubMed Web of Science ®Google Scholar
• Jones LM, Broz ML, Ranger JJ, Ozcelik J, Ahn R, Zuo D, Ursini-Siegel J, Hallett MT, Krummel M, Muller WJ. STAT3 establishes an immunosuppressive microenvironment during the early stages of breast carcinogenesis to promote tumor growth and metastasis. Cancer Res 2016; 76:1416-28; PMID: 26719528; http://dx.doi.org/10.1158/0008-5472.CAN-15-2770
   PubMed Web of Science ®Google Scholar
• Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7:41-51; PMID: 17186030; http://dx.doi.org/10.1038/nri1995
   PubMed Web of Science ®Google Scholar
• Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mulé J, Kerr WG et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11:1314-21; PMID: 16288283; http://dx.doi.org/10.1038/nm1325
   PubMed Web of Science ®Google Scholar
• Hossain DM, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, Saha T, Chakraborty S, Kar RK, Das T et al. FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 2013; 39:1057-69; PMID: 24315995; http://dx.doi.org/10.1016/j.immuni.2013.11.005
   PubMed Web of Science ®Google Scholar
• Pallandre JR, Brillard E, Crehange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P et al. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity. J Immunol 2007; 179:7593-604; PMID: 18025205; http://dx.doi.org/10.4049/jimmunol.179.11.7593
   PubMed Web of Science ®Google Scholar
• Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501:346-54; PMID: 24048067; http://dx.doi.org/10.1038/nature12626
   PubMed Web of Science ®Google Scholar
• Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, Valle LD, Trillo-Tinoco J, Maj T, Zou W et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res 2015; 3:1236-47; PMID: 26025381; http://dx.doi.org/10.1158/2326-6066.CIR-15-0036
   PubMed Web of Science ®Google Scholar
• De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH, Budhu S, Ghosh A, Pink M, Tchaicha J et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells. Nature 2016; 539:443-7; PMID: 27828943; http://dx.doi.org/10.1038/nature20554
   PubMed Web of Science ®Google Scholar
• Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, Gao W, Saito TI, Lo Celso C, Tsuyuzaki H et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 2011; 474:216-9; PMID: 21654805; http://dx.doi.org/10.1038/nature10160
   PubMed Web of Science ®Google Scholar
• Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR Jr et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28:546-58; PMID: 18387831; http://dx.doi.org/10.1016/j.immuni.2008.02.017
   PubMed Web of Science ®Google Scholar
• Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol 2005; 12:882-93; PMID: 16108723; http://dx.doi.org/10.1089/cmb.2005.12.882
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43:e47; PMID: 25605792; http://dx.doi.org/10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate; A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995; 57:289-300; http://dx.doi.org/10.2307/2346101
   Google Scholar
• Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80; PMID: 15461798; http://dx.doi.org/10.1186/gb-2004-5-10-r80
   PubMed Web of Science ®Google Scholar
• Huber, W., Carey, V.J., Gentleman, R., Anders, S., Carlson, M., Carvalho, B.S., Bravo, H.C., Davis, S., Gatto, L., Girke, T., et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 2015; 12, 115–121.
   Google Scholar